Clinical trial
Conduction System PACing and Atrioventricular Node Ablation in Patients With hEart Failure, Left Ventricular Ejection Fraction >40% and Permanent Atrial FIBrilation: the PACE-FIB Trial
NCT05029570 is registered in ClinicalTrials.gov with Daniel Rodríguez Muñoz as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Conduction System PACing and Atrioventricular Node Ablation in Patients With hEart Failure, Left Ventricular Ejection Fraction >40% and Permanent Atrial FIBrilation: the PACE-FIB Trial
- Lead sponsor
- Daniel Rodríguez Muñoz
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- April 29, 2022
- Completion date
- September 30, 2030
- Enrollment
- 334 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.